MARKET

HROW

HROW

Harrow Health Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.610
-0.010
-0.28%
Closed 16:00 04/03 EDT
OPEN
3.620
PREV CLOSE
3.620
HIGH
3.835
LOW
3.520
VOLUME
66.54K
TURNOVER
--
52 WEEK HIGH
8.99
52 WEEK LOW
3.330
MARKET CAP
92.15M
P/E (TTM)
-130.7971
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average HROW stock price target is 12.00 with a high estimate of 12.00 and a low estimate of 12.00.

EPS

HROW News

More
  • ImprimisRx® Announces Exclusive Agreement with Doxy.me to Provide Healthcare Professionals with Telemedicine Services
  • GlobeNewswire · 03/24 12:30
  • Harrow Health: Fiscally Disciplined, Entrepreneurially Bold
  • Seeking Alpha - Article · 03/17 17:10
  • Harrow Health Appoints Teresa Sparks to its Board of Directors
  • GlobeNewswire · 03/17 12:30
  • B. Riley FBR Maintains Buy on Harrow Health, Lowers Price Target to $12
  • Benzinga · 03/16 11:15

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About HROW

Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., owns diversified portfolio of healthcare businesses. The Company’s subsidiaries are Imprimis Pharmaceuticals Inc. and Park Compounding. Imprimis Pharmaceuticals Inc. is engaged in ophthalmology pharmaceutical compounding business. Park Compounding is engaged in compounding business and also offers strategic research and development facilities, which is engaged in developing and dispensing medicines for individual patients.
More

Webull offers kinds of Harrow Health Inc stock information, including NASDAQ:HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions.